DelveInsight’s “Angioedema Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Angioedema, historical and forecasted epidemiology as well as the Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Angioedema market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Angioedema market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Angioedema Market Insights
Angioedema Overview
Angioedema is a condition when a body component becomes unexpectedly enlarged. If an allergic reaction is what caused the swelling, you will typically experience a raised, itchy rash (hives). The face, especially the lips, mouth, and eyelids, is one of the parts of the body that frequently affects the feet or hands.
Some of the key facts of the Angioedema Market Report:
- The Angioedema market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- Hereditary angioedema affects 1 in every 50,000 people globally, with reported prevalence ranges from 1:10,000 to 1:150,000
- Angioedema is a common condition, affecting about 10-20% of people during their life, although some types are more common than others
- Key Angioedema Companies: Dyax Corp., Takeda, Ionis Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring, Takeda, Shire, Pharming Group, and others
- Key Angioedema Therapies: Lanadelumab, DX-2930, Icatibant, Donidalorsen, BCX7353, IONIS-PKK-LRx, KVD900, CSL312, and others
Get a Free sample for the Angioedema Market Report -
https://www.delveinsight.com/sample-request/angioedema-market
Key benefits of the Angioedema Market report:
- Angioedema market report covers a descriptive overview and comprehensive insight of the Angioedema Epidemiology and Angioedema market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Angioedema market report provides insights on the current and emerging therapies.
- Angioedema market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Angioedema market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Angioedema market.
Download the report to understand which factors are driving Angioedema epidemiology trends @ Angioedema Epidemiological Insights
Angioedema Market
The dynamics of the Angioedema market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
Angioedema Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Angioedema Epidemiology Segmentation:
The Angioedema market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Angioedema
- Prevalent Cases of Angioedema by severity
- Gender-specific Prevalence of Angioedema
- Diagnosed Cases of Episodic and Chronic Angioedema
Angioedema Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Angioedema market or expected to get launched during the study period. The analysis covers Angioedema market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Angioedema Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Angioedema market share @ Angioedema market forecast
Angioedema Therapies and Key Companies
- Lanadelumab: Takeda Development Center Americas, Inc.
- DX-2930: Dyax Corp.
- Icatibant: Takeda
- Donidalorsen: Ionis Pharmaceuticals, Inc.
Angioedema Market Strengths
- Increasing identification of a novel genetic mutation in various regions warranting further focus on the types and associated pathophysiology, including recognition of hormonal changes
Scope of the Angioedema Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Angioedema Companies: Dyax Corp., Takeda, Ionis Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring, Takeda, Shire, Pharming Group, and others
- Key Angioedema Therapies: Lanadelumab, DX-2930, Icatibant, Donidalorsen, BCX7353, IONIS-PKK-LRx, KVD900, CSL312, and others
- Angioedema Therapeutic Assessment: Angioedema current marketed and Angioedema emerging therapies
- Angioedema Market Dynamics: Angioedema market drivers and Angioedema market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Angioedema Unmet Needs, KOL’s views, Analyst’s views, Angioedema Market Access and Reimbursement
Angioedema Market Opportunities
- Proliferating demand for therapies with improved patient compliance, fewer side effects, improved resistance profile, and long-acting therapies
Table of Contents
1. Angioedema Market Report Introduction
2. Executive Summary for Angioedema
3. SWOT analysis of Angioedema
4. Angioedema Patient Share (%) Overview at a Glance
5. Angioedema Market Overview at a Glance
6. Angioedema Disease Background and Overview
7. Angioedema Epidemiology and Patient Population
8. Country-Specific Patient Population of Angioedema
9. Angioedema Current Treatment and Medical Practices
10. Angioedema Unmet Needs
11. Angioedema Emerging Therapies
12. Angioedema Market Outlook
13. Country-Wise Angioedema Market Analysis (2019–2032)
14. Angioedema Market Access and Reimbursement of Therapies
15. Angioedema Market Drivers
16. Angioedema Market Barriers
17. Angioedema Appendix
18. Angioedema Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Angioedema treatment, visit @ Angioedema Medications
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
